- Tytuł:
-
Study protocol of the TRICOLORE trial: a randomized phase III study of oxaliplatin-based chemotherapy versus combination chemotherapy with
S -1, irinotecan, and bevacizumab as first-line therapy for metastatic colorectal cancer. - Autorzy:
- Źródło:
- BMC cancer [BMC Cancer] 2015 Sep 09; Vol. 15, pp. 626. Date of Electronic Publication: 2015 Sep 09.
- Typ publikacji:
-
Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.
S . Gov't - MeSH Terms:
-
Adenocarcinoma /*drug therapy
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Colorectal Neoplasms/*drug therapy
Organoplatinum Compounds/*therapeutic useAdenocarcinoma /mortality ;Adenocarcinoma /pathology ; Adult ; Aged ; Aged, 80 and over ; Bevacizumab/administration & dosage ; Camptothecin/administration & dosage ; Camptothecin/analogs & derivatives ; Clinical Trials, Phase III as Topic ; Colorectal Neoplasms/mortality ; Colorectal Neoplasms/pathology ; Cost-Benefit Analysis ; Disease-Free Survival ; Drug Combinations ; Female ; Fluorouracil/therapeutic use ; Health Care Costs ; Humans ; Irinotecan ; Leucovorin/therapeutic use ; Male ; Middle Aged ; Oxaliplatin ; Oxonic Acid/administration & dosage ; Quality of Life ; Tegafur/administration & dosage ; Young Adult - SCR Protocol:
- Folfox protocol
Czasopismo naukowe